TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NUVB

Nuvation Bio Inc

Healthcare · Biotechnology

5.90$ -3.6% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Nuvation Bio Inc (NUVB)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 75.3% of the shares are freely tradable; institutional investors hold 64.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 64.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 18.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 75.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 25.5%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 350Mio.

Largest Shareholders

No ownership data is available for this stock yet.

Insider holdings

Insider holdings NUVB
Person Role Shares Value As of Type
Sauvage Philippe Chief Financial Officer 54,131 319,373 $ Jul 15, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 19, 2026 Hattersley Gary CHIEF SCIENTIFIC OFFICER Sell 100,000 7.09 709,240
Aug 19, 2026 Hattersley Gary CHIEF SCIENTIFIC OFFICER Other 100,000 1.87 187,000
Jul 15, 2026 Sauvage Philippe Chief Financial Officer Other 1 1.97 2
Jul 15, 2026 Sauvage Philippe Chief Financial Officer Other 39,999 2.17 86,798
Apr 17, 2026 Dongfang Liu Insider Sell 50,000 5.02 251,000
Apr 17, 2026 Kerry Wentworth Insider Sell 36,750 5.01 184,118

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?